Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy For Locally Advanced Breast Cancer

Inclusion Criteria:

- Female patients over 18 years of age with biopsy-proven breast cancer

- Patients presenting with locally advanced disease in the breast (cT4) and/or in the
nodes (cN2/N3) as assessed by clinical exam and imaging

- Patients presenting to surgery clinic after receipt of NAC at outside hospital with
documentation of cT4 or cN2/3 disease on initial outside physical exam and imaging
studies

- Patients receiving NAC and having a nodal complete clinical response as assessed by
physical exam

Exclusion Criteria:

- Patients with a prior history of ipsilateral breast cancer

- Pregnant patients

- Patients with persistent palpable axillary nodes after NAC, as assessed by physical
exam

- Patients not consenting to ALND